Workflow
Xylem Inc(XYL.US)Pure~play water leader with attractive growth profile. Initiate Buy.
UBS· 2024-08-13 08:48
Investment Rating - The report initiates coverage of Xylem Inc with a Buy rating and a price target of $165, indicating a favorable outlook for the company [1][5][9]. Core Viewpoints - Xylem Inc is positioned as the leading pure-play water company, expected to achieve a mid-single-digit (MSD+) growth profile, which is less cyclical compared to peers. The company has a margin expansion opportunity of approximately 100 basis points per year [1][5][9]. - The growth outlook is supported by several secular trends, including aging water infrastructure, government funding for upgrades, stricter regulations on water quality, and global urbanization [3][5][25]. - The company generated approximately $7.4 billion in sales for FY23, with a diverse product suite that includes water flow, test and measurement, and treatment/filtration equipment [7][9]. Summary by Sections Investment Thesis - Xylem is expected to benefit from substantial demand for replacement and new equipment due to aging infrastructure in developed economies, supported by government funding and regulations addressing water contamination [3][5][25]. - The company is projected to achieve a sales compound annual growth rate (CAGR) of around 6% through 2028, which is above the market's expectations [3][5][27]. Financial Projections - Revenue projections for Xylem are as follows: $8.6 billion in 2024, $9.0 billion in 2025, and $9.6 billion in 2026, with net earnings expected to reach $1.0 billion in 2024 and $1.2 billion in 2025 [1][12]. - The report anticipates an EBITDA margin improvement from 16% in 2024 to 20% by 2028, reflecting the company's operational efficiency and strategic pricing actions [4][12]. Market Drivers - Key market drivers include the estimated $625 billion funding need for national drinking water infrastructure over the next 20 years, with over $50 billion allocated by the Bipartisan Infrastructure Law for improvements [6][26]. - Urbanization trends indicate that approximately 68% of the global population will live in urban areas by 2050, increasing the demand for water infrastructure and treatment solutions [6][26]. Competitive Positioning - Xylem's balance sheet is strong, with a net debt to EBITDA ratio of 0.7x, positioning the company favorably against its peers [5][11]. - The company is currently trading at a premium compared to its peers, reflecting its higher growth potential and lower cyclicality [14][18].
US Insurance Wrapping up 2Q24 Earnings Season
UBS· 2024-08-13 08:48
ab 13 August 2024 Global Research and Evidence Lab Equities Americas Insurance US Insurance Wrapping up 2Q24 Earnings Season Brokers and Personal Lines Reverse Last Week's Gains P&C insurers we cover were down 0.8% over the week, underperforming both Fins (+0.8%) and the S&P 500 (~flat). Brokers were down 1.9% with RYAN (-5%) and GSHD (-4.9%). Personal lines were also down with KMPR (-5.3%) and ALL (-3.3%). Commercial lines we cover were flat on average with WRB (+3.5%) and AIZ (+2.4%) offset by JRVR (-6.4% ...
China Consumer Staples Sector:Channel check with a frozen food distributor in East China
UBS· 2024-08-13 08:47
ab 13 August 2024 Global Research and Evidence Lab China Consumer Staples Sector Channel check with a frozen food distributor in East China Product upgrades and pre-prepared dishes are key industry growth drivers We hosted a conference call with a frozen food distributor in East China to track recent industry trends. Overall, the distributor stays optimistic about the growth potential of frozen food industry, primarily driven by the increase in ASPs due to product upgrades, while volume growth is relatively ...
Peloton Interactive Inc(PTON.US)July Web Traffic for Interactive Visits down~12% YOY;Q4 Preview
UBS· 2024-08-13 08:47
ab 13 August 2024 Global Research and Evidence Lab Powered by YES UBS Evidence Lab Peloton Interactive Inc July Web Traffic for Interactive Visits down -12% YOY; Q4 Preview July is down less than June-May declines of -17-19% Our analysis of total interactive visits to the Peloton website, with interactive visits defined as total visits excluding bounced visits (those that enter a site, take no action and then leave), shows July web traffic is down -12%, improving from steeper declines in May down -19% and J ...
Natura &Co(NTCO3.BZ)Sharp loss, despite improved results in LatAm; Avon Chapter 11
UBS· 2024-08-13 08:47
ab 13 August 2024 Global Research and Evidence Lab First Read Natura &Co Sharp loss, despite improved results in LatAm; Avon Chapter 11 Avon's chapter 11 drives sharp net loss Although 2Q adj. EBITDA of 804m came-in just slightly below of expectations (UBSe R$827m), net loss came-in at a sharp -R$859m (vs. UBSe at +R$80m), due to a +R $725m write-off in Avon-related deferred taxes, as the company announced the Chapter 11 request of its subsidiary Avon Products, holding of the Avon beauty brand. As part of t ...
US Softlines Retail:Expert Call Recap: Specialty Apparel Retail: Backto~School Starts Strong
UBS· 2024-08-13 08:47
ab 13 August 2024 Global Research and Evidence Lab US Softlines Retail Expert Call Recap: Specialty Apparel Retail: Backto-School Starts Strong Specialty Apparel Retail industry sales growth trends have accelerated: The market is wondering how the Back-to-School (BTS) season has started for mallbased specialty apparel retailers. To address this question, we hosted a call on 8/9/24 with a senior leader of a specialty retail organization focused mainly on teen retail and fast fashion. The key conclusion is BT ...
Kohl's Corp(KSS.US)UBS Evidence Lab inside: 2Q Preview,We See a Balanced Upside/Downside Skew
UBS· 2024-08-13 08:47
Powered by UBS Evidence Lab ab 13 August 2024 Global Research and Evidence Lab YES | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|--------------|---------------------------------------|--------------|-------- ...
ISS A/S:H1 profits in~line, but with some mixed details
UBS· 2024-08-13 08:47
First Read ISS A/S H1 profits in-line, but with some mixed details Q: How did the results compare vs expectations? A: Q2 organic growth and H1 profits were broadly in-line with expectations, with guidance items reaffirmed and a modest buyback increase. Some of the details (e.g. outlook for net new contracts being lowered for FY'24e, despite some recent wins) were more mixed. Q: What were the most noteworthy areas in the results? A: Organic growth of +5.8% y/y in Q2'24 was in-line with consensus and similar ...
HF Sinclair Corp(DINO.US) Call takeaways and Adjusting Estimates
UBS· 2024-08-13 08:47
Investment Rating - The report assigns a "Buy" rating for HF Sinclair Corp (DINO) with a 12-month price target adjusted to US$70.00 from the previous US$73.00 [1]. Core Insights - HF Sinclair Corp (DINO) provided guidance for 3Q24 throughput of 570-600 mb/d, accounting for turnarounds at the Parco and El Dorado refineries [1]. - The company has signed contracts to convert 150 stores to its branded wholesale sites, expecting growth of approximately 10% over the next 6 to 12 months [1]. - The renewable diesel business has become profitable in a low-margin environment, with DINO increasing utilization of pretreatment units and lowering operating costs [1]. - The Lubes business is projected to run at an EBITDA of US$350 million, with an EBITDA margin of 12-13% [1]. - DINO anticipates widening Canadian crude differentials in the next 12-24 months, with spot WTI-WCS already widening to US$15/bbl [1]. - The company is on track to exceed a 50% payout ratio as it continues to reward shareholders [1]. - Adjusted estimates reflect a decrease in EPS for 2024E to US$4.43 from US$5.18 and for 2025E to US$6.56 from US$7.11 [1]. Financial Summary - Revenues are projected to be US$32,031 million for 2024E, with a slight decrease to US$31,808 million in 2025E [2]. - EBITDA is expected to decline to US$1,970 million in 2024E, with a recovery to US$2,329 million in 2025E [2]. - Net earnings are forecasted at US$842 million for 2024E, increasing to US$1,160 million in 2025E [2]. - The diluted EPS is expected to be US$4.43 for 2024E, with a rise to US$6.56 in 2025E [2]. - The company’s net debt is projected to be US$1,866 million for 2024E, decreasing to US$1,739 million in 2025E [2].
US Asset Managers:IVZ and BLK stand alone with inflows in a choppy but upwardly trending tape
UBS· 2024-08-13 08:47
ab 13 August 2024 Global Research and Evidence Lab US Asset Managers IVZ and BLK stand alone with inflows in a choppy but upwardly trending tape Broad beta tailwinds partially offset by outflows, ex. IVZ & BLK July AUM reports reflected mixed markets (Nasdaq down 0.8% and S&P 500 up 1.1% in July), but total AUM higher across the board. Highlights: 1. IVZ reported robust inflows in July (+$10.8bn), primarily in equities (+$7.4bn) and fixed income (+$2.2bn). This has become a positive trend for the firm with ...